Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Vaccine to Prevent West Nile Virus Disease [Phase 1]

View source ↗

Summary

Phase 1 trial of a West Nile virus vaccine completed in healthy volunteers to assess safety and preliminary immune response.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • West Nile virus vaccine (Phase 1 trial) (West Nile virus vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Healthy, West Nile Fever | Phase 1 | Status: COMPLETED